产品中心 抗体 其他一抗

所有图片(1/3)

CD69 Rat mAb (S-878-22)

Early activation antigen CD69

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B0627
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rat
  • 分子别名

    Early activation antigen CD69
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Membrane
  • Accession

    P37217
  • 克隆号

    S-878-22
  • 抗体类型

    Rat mAb
  • 抗体同种型

    IgG2a
  • 反应种属 ?

    Ms
  • 纯化方式

    Protein G
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20°C as supplied

  • 应用

    FCM

    ICC ?

  • 稀释度

    应用 稀释度
    ICC 1:500
    FCM 1:200
背景介绍
  • CD69 protein is a type II transmembrane glycoprotein belonging to the C-type lectin receptor family and a member of the NK cell signaling transduction gene complex family. It is the earliest surface antigen expressed after the activation of T lymphocytes and can serve as a co-stimulatory signal to promote further activation and proliferation of T cells. Additionally, CD69 is also induced to express on NK cells, B cells, macrophages, neutrophils, and eosinophils. When external stimuli disappear, the expression of CD69 on activated T cells rapidly decreases. Furthermore, the expression of CD69 protein is associated with various disease states. For instance, it is closely related to the occurrence and development of malignancies, and its expression level in patients with chronic lymphocytic leukemia is tightly linked to factors such as the number of peripheral blood lymphocytes and clinical staging, indicating its potential as a new prognostic indicator for this disease. CD69 is also considered a marker of activation for eosinophils and certain other cells, and its high-level expression may suggest the presence of immune system diseases, hematological disorders, such as rheumatoid arthritis, systemic lupus erythematosus, leukemia, lymphoma, and more.

  • 流式分析

    • Flow cytometric analysis of C57BL/6 mouse splenocytes, treated overnight with 3μg/ml Concanavalin A (Red) or untreated (Green), labeling CD69 at 1/200 dilution (1 μg) compared with a Rat monoclonal IgG isotype control (Black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Rat IgG Alexa Fluor® 488 was used as the secondary antibody.

  • 免疫细胞化学

    • ICC shows positive staining in Mouse splenocytes cells treated with Concanavalin A (3 µg/ml,overnight). Anti- CD69 antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rat IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue).

    • Negative control: ICC shows weak staining in Mouse splenocytes cells untreated with Concanavalin A (3 µg/ml, overnight). Anti- CD69 antibody was used at 1/500 dilution and incubated overnight at 4°C. Goat polyclonal Antibody to Rat IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue).

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)